Corrigendum to ‘L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cells’

Kim, T.; Lee, W.J.; Shin, J.S.; Hwang, I.Y.; Shin, Y.J.; Kim, J.H.; Gong, E.Y.; Kim, S.M.; Lee, E.Y.; Lee, S.; Kim, J.E.; Hong, S.W.; Moon, J.H.; Lee, D.H.; Jung, S.A.; Kim, K.P.; Hong, Y.S.; Lee, J.S.; Jin, D.H.

doi:10.1016/j.freeradbiomed.2016.07.017

Record: found
Abstract: not found
Article: not found

Corrigendum to ‘L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cells’

Author(s): S.A. Jung , D.H. Lee , J.H. Moon , S.W. Hong , J.S. Shin , I.Y. Hwang , Y.J. Shin , J.H. Kim , E.Y. Gong , S.M. Kim , E.Y. Lee , S. Lee , J.E. Kim , K.P. Kim , Y.S. Hong , J.S. Lee , D.H. Jin , T. Kim , W.J. Lee

Publication date Created: August 2016

Publication date (Print): August 2016

Journal: Free Radical Biology and Medicine

Publisher: Elsevier BV

Read this article at

ScienceOpenPublisher

Bookmark

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Related collections

Author and article information

Journal

Title: Free Radical Biology and Medicine

Abbreviated Title: Free Radical Biology and Medicine

Publisher: Elsevier BV

ISSN (Print): 08915849

Publication date Created: August 2016

Publication date (Print): August 2016

Volume: 97

Page: 620

Article

DOI: 10.1016/j.freeradbiomed.2016.07.017

SO-VID: f6db0847-ec84-4092-975d-b805d0fac5ca

License:

https://www.elsevier.com/tdm/userlicense/1.0/

History

Data availability:

Corrigendum to ‘L-Ascorbic acid can abrogate SVCT-2-dependent cetuximab resistance mediated by mutant KRAS in human colon cancer cells’

Read this article at

Related collections

Gamma Delta T cells

Author and article information

Journal

Article

History

Comments

Comment on this article

Similar content 1,732

Cited by 1